Myelin oligodendrocyte glycoprotein (MOG-IgG1) fluorescence-activated cell sorting (FACS) assay, serum

Alphabetical Test listing

Myelin oligodendrocyte glycoprotein (MOG-IgG1) fluorescence-activated cell sorting (FACS) assay, serum-994

  
Myelin oligodendrocyte glycoprotein (MOG-IgG1) fluorescence-activated cell sorting (FACS) assay, serum
  
994
  
LAB994
  
MSO
  
ADEM antibody
MOG-IgG
MOG
Optic neuritis antibody
NMO antibody
Transverse myelitis antibody
Vision loss antibody
  
  • Diagnosis of inflammatory demyelinating diseases (IDD) with similar phenotype to neuromyelitis optica (NMO) spectrum disorder (NMOSD), including optic neuritis (single or bilateral) and transverse myelitis
  • Diagnosis of autoimmune myelin oligodendrocyte glycoprotein (MOG)-opathy
  • Diagnosis of NMO
  • Distinguishing NMOSD, acute disseminated encephalomyelitis (ADEM), optic neuritis, and transverse myelitis from multiple sclerosis early in the course of disease
  • Diagnosis of ADEM
  • Prediction of a relapsing disease course
  

For optimal antibody detection, recommend blood collection to occur before initiation of immunosuppressant medication.

  
Serum
  

Gold serum separator (SST) tube

  
2.0 mL
  
1.0 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  

Red serum vial/tube, 5 mL

  
  1. Allow sample to clot
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Screw cap transfer vial/tube (Mayo T914), labelled as serum
  

Screw cap transfer vial/tube (Mayo T914)

  

Refrigerated (preferred) - 28 days

Frozen - 28 days

Ambient - 72 hours

  
  • Gross hemolysis
  • Gross lipemia
  • Gross icterus
  
Mayo Clinic Laboratories (MOGFS): R-NX
  
Mo, Tu, Th; 6pm
  
5 - 8 days
  

Flow Cytometry

  

Negative

  
86363
86256 (if appropriate)
  
11/10/2017
  
01/04/2024
  
01/04/2024